RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ALK-Abello A/S Stock

ALK-Abello A/S Market capitalization 2024

ALK-Abello A/S Market capitalization

35.69 B DKK

Ticker

ALK B.CO

ISIN

DK0060027142

WKN

A0H0J1

In 2024, ALK-Abello A/S's market cap stood at 35.69 B DKK, a 57.33% increase from the 22.69 B DKK market cap in the previous year.

The ALK-Abello A/S Market capitalization history

YEARMarket Capitalization (undefined DKK)
202319.5
2022166.34
2021626.17
2020420.3
2019293.69
2018208.31
2017192.29
2016196.86
20157.69

ALK-Abello A/S Aktienanalyse

What does ALK-Abello A/S do?

ALK-Abello A/S is a Danish company specializing in the production of allergy-based products and therapies. It was founded in 1923 by Dr. H. C. Harald Petersen and is headquartered in Hørsholm, Denmark. The company's history began with Dr. Petersen's discovery that allergens could be administered to trigger an immune reaction in a control system. He developed a therapy for hay fever using pollen extracts from grasses, flowers, and trees to desensitize the immune system to these allergens. In 1940, ALK introduced the first specific immunotherapy (SIT) for protection against pollen allergies. ALK-Abello A/S is a leading provider of allergen-based therapeutics and diagnostic tests for allergic diseases. The company offers two main products: allergen immunotherapies and diagnostic tests for allergic diseases. These products are offered in 28 countries worldwide, and the company is the largest provider of allergen-based therapeutics in Europe. ALK-Abello A/S operates three main divisions: allergen immunotherapies, diagnostic products, and other specialty products. The allergen immunotherapies are based on allergen extracts and aim to train the immune system to tolerate allergens by administering a small amount that is enough to trigger an immune response but not cause an allergic reaction. These therapies are used for various allergic diseases, including hay fever, asthma, and allergic skin conditions. The diagnostic products of ALK-Abello A/S are used for the diagnosis of allergic diseases. There are different types of diagnostic tests, including skin tests, in vitro diagnostic tests, and specific IgE tests (blood tests). Other specialty products of ALK-Abello A/S include products for the treatment of specific allergies or diseases related to allergies. Examples include adrenaline auto-injectors for the treatment of anaphylactic shock and nasal sprays for the treatment of hay fever. In summary, ALK-Abello A/S is a leading provider of allergy products and therapies, with a long history in the development of allergen-based therapeutics. The company operates three main divisions and offers a wide range of products that can be used for the diagnosis and treatment of allergic diseases. ALK-Abello A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring ALK-Abello A/S's Market Capitalization

ALK-Abello A/S's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of ALK-Abello A/S's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

ALK-Abello A/S's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in ALK-Abello A/S’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about ALK-Abello A/S stock

What is the current ALK-Abello A/S market capitalization?

The current market capitalization of ALK-Abello A/S is 35.69 B DKK.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like ALK-Abello A/S.

How has the market capitalization of ALK-Abello A/S developed in recent years?

The market capitalization of ALK-Abello A/S has increased/decreased by 57.33% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of ALK-Abello A/S?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of ALK-Abello A/S?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of ALK-Abello A/S have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does ALK-Abello A/S pay?

Over the past 12 months, ALK-Abello A/S paid a dividend of 5 DKK . This corresponds to a dividend yield of about 3.1 %. For the coming 12 months, ALK-Abello A/S is expected to pay a dividend of 12.69 DKK.

What is the dividend yield of ALK-Abello A/S?

The current dividend yield of ALK-Abello A/S is 3.1 %.

When does ALK-Abello A/S pay dividends?

ALK-Abello A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of ALK-Abello A/S?

ALK-Abello A/S paid dividends every year for the past 6 years.

What is the dividend of ALK-Abello A/S?

For the upcoming 12 months, dividends amounting to 12.69 DKK are expected. This corresponds to a dividend yield of 7.87 %.

In which sector is ALK-Abello A/S located?

ALK-Abello A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von ALK-Abello A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ALK-Abello A/S from 3/20/2017 amounting to 5 DKK, you needed to have the stock in your portfolio before the ex-date on 3/16/2017.

When did ALK-Abello A/S pay the last dividend?

The last dividend was paid out on 3/20/2017.

What was the dividend of ALK-Abello A/S in the year 2023?

In the year 2023, ALK-Abello A/S distributed 0 DKK as dividends.

In which currency does ALK-Abello A/S pay out the dividend?

The dividends of ALK-Abello A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ALK-Abello A/S

Our stock analysis for ALK-Abello A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ALK-Abello A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.